Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease. 2018

Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
Laboratory of Clinical and Experimental Neuroscience, Division of Cell Biology and Physiology, CSIR-Indian Institute of Chemical Biology, 4-Raja S. C. Mullick Road, Jadavpur, Kolkata, 700 032, India.

Since substantia nigra (SN) and ventral tegmental area (VTA) dopaminergic neurons are, respectively, susceptible or largely unaffected in Parkinson's disease (PD), we searched for protein(s) that regulates this differential sensitivity. Differentially, expressed proteins in SN and VTA were investigated employing two-directional gel electrophoresis- matrix-assisted laser desorption ionization time of flight (MALDI-TOF-TOF) analyses. Prohibitin, which is involved in mitochondrial integrity, was validated using immunoblot, qRT-PCR, and immunohistochemistry in normal mice as well as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-model, PD postmortem human brains, and PD cybrids. In prohibitin over-expression, differentiated SH-SY5Y neurons were investigated for their susceptibility to PD neurotoxin, 1-methyl-4-phenyl-pyridnium (MPP+). Prohibitin, Hsc73, and Cu-Zn superoxide dismutase (Cu-Zn SOD) were highly expressed in VTA, whereas heat shock protein A8 (HSPA8) and 14-3-3ζ/δ were 2-fold more in SN. Prohibitin level was transiently increased in SN but unaltered in VTA on the third day of MPTP-induced mice, whereas in PD human brains, prohibitin was depleted in both these regions. Parallel to mouse SN, an enhanced prohibitin expression was found in human PD cybrids. In MPP+-induced cellular model of PD, reduction in prohibitin level was found to be associated with a loss in its binding with Ndufs3, a mitochondrial complex I protein partner. Prohibitin over-expression resisted MPP+-induced neuronal death by restoring mitochondrial membrane potential, preventing reactive oxygen species generation and cytochrome c release into cytosol. These protective phenomena exerted by prohibitin over-expression altogether hinder caspase 3 activation induced by MPP+. These results imply that prohibitin is an important negotiator protein that regulates dopaminergic cell death in SN and their protection in VTA in PD.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011180 Postmortem Changes Physiological changes that occur in bodies after death. Adipocere,Algor Mortis,Cruor,Livor Mortis,Change, Postmortem,Changes, Postmortem,Postmortem Change
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
July 2019, Iranian journal of basic medical sciences,
Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
April 2008, Nucleic acids research,
Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
March 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration,
Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
March 2007, Neuroscience letters,
Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
September 2009, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
January 2007, Progress in brain research,
Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
January 2021, Frontiers in synaptic neuroscience,
Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
January 1993, Advances in neurology,
Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
April 2000, Journal of neurology,
Debashis Dutta, and Nilufar Ali, and Emili Banerjee, and Raghavendra Singh, and Amit Naskar, and Ramesh Kumar Paidi, and Kochupurackal P Mohanakumar
January 2009, Journal of neural transmission. Supplementum,
Copied contents to your clipboard!